Furthermore, both current types of PEG-IFN-α, that is, PEG-IFN-α2a and 2b, were administrated in all six trials, so the type of IFN-α may be ignored when prophylactic SSRIs are used in patients with CHC. The gene discussed is IFNA17; the disease is cryohydrocytosis.